UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000019999
Receipt No. R000023087
Official scientific title of the study Safety and efficay assessment of adenosine A2A receptor ligand [C-11]Preladenant in healthy volunteers.
Date of disclosure of the study information 2015/12/01
Last modified on 2017/11/20 (Ver. 7)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Safety and efficay assessment of adenosine A2A receptor ligand [C-11]Preladenant in healthy volunteers.
Title of the study (Brief title) First-in-human study of [C-11] Preladenant.
Region
Japan

Condition
Condition Healthy volunteer
Classification by specialty
Neurology Radiology Neurosurgery
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 First-in-human study of [C-11]Preladenant. Assessment of safety, efficacy and dosimetry in healthy volunteers.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase Phase I

Assessment
Primary outcomes Safety: Adverse Drug Reaction (symptoms, blood pressure, respiratory rate, heart rate, general blood tests)
Efficacy: Quality and analyzability of PET/CT image.
Dosimetry
Date of evaluation: on the day and one week after the PET scan
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Medicine
Interventions/Control_1 The dosage in the vain of [C-11]CB184 for PET/CT imaging.
Term of injection: On the day of PET/CT imaging.
Dosage:185-740 MBq (Maximum substance at 37 microgram)
Number of injection: once
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
60 years-old >=
Gender Male
Key inclusion criteria 1. The subject who has intention to participate in this study, and signed informed consent.
2. Male subject of >=20 and =<60 years old.
3. The subject who judged by clinical investigator by means of physical examination and laboratory tests to be eligible as a participant in this study.
Key exclusion criteria 1. The subject who has dysfunction in the liver / kidney.
2. The subject who has abnormal findings in the central nervous system.
3. The subject having cardiac failure.
4. The subject with a history of a drug or food allergy.
5. The subject who juddged by the clinical investigator to be inappropriate as a participant in this study.
Target sample size 15

Research contact person
Name of lead principal investigator Kenji Ishii
Organization Tokoyo Metropolitan Institute of Gerontology
Division name Research Team for Neuroimaging
Address 35-2 Sakae-cho, Itabashi-ku, Tokyo
TEL 03-3964-3241
Email ishii@pet.tmig.or.jp

Public contact
Name of contact person Kenji Ishii
Organization Tokoyo Metropolitan Institute of Gerontology
Division name Research Team for Neuroimaging
Address 35-2 Sakae-cho, Itabashi-ku, Tokyo
TEL 03-3964-3241
Homepage URL
Email ishii@pet.tmig.or.jp

Sponsor
Institute Tokoyo Metropolitan Institute of Gerontology
Institute
Department

Funding Source
Organization Tokyo Metropolitan Institute of Gerontology
Organization
Division
Category of Funding Organization Local Government
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 地方独立行政法人東京都健康長寿医療センター研究所

Other administrative information
Date of disclosure of the study information
2015 Year 12 Month 01 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 10 Month 14 Day
Anticipated trial start date
2015 Year 12 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 11 Month 30 Day
Last modified on
2017 Year 11 Month 20 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023087